Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Bovine T cell receptors and γδ WC1 co-receptor transcriptome analysis during the first month of life.

Damani-Yokota P, Gillespie A, Pasman Y, Merico D, Connelley TK, Kaushik A, Baldwin CL.

Dev Comp Immunol. 2018 Nov;88:190-199. doi: 10.1016/j.dci.2018.07.023. Epub 2018 Jul 23.

PMID:
30048698
2.

Variegated Transcription of the WC1 Hybrid PRR/Co-Receptor Genes by Individual γδ T Cells and Correlation With Pathogen Responsiveness.

Damani-Yokota P, Telfer JC, Baldwin CL.

Front Immunol. 2018 May 7;9:717. doi: 10.3389/fimmu.2018.00717. eCollection 2018.

3.

Synthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probes.

Chea EK, Fernández-Tejada A, Damani P, Adams MM, Gardner JR, Livingston PO, Ragupathi G, Gin DY.

J Am Chem Soc. 2012 Aug 15;134(32):13448-57. doi: 10.1021/ja305121q. Epub 2012 Aug 6.

4.

Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins.

Ragupathi G, Damani P, Deng K, Adams MM, Hang J, George C, Livingston PO, Gin DY.

Vaccine. 2010 Jun 11;28(26):4260-7. doi: 10.1016/j.vaccine.2010.04.034. Epub 2010 May 5.

5.

Design and synthesis of potent Quillaja saponin vaccine adjuvants.

Adams MM, Damani P, Perl NR, Won A, Hong F, Livingston PO, Ragupathi G, Gin DY.

J Am Chem Soc. 2010 Feb 17;132(6):1939-45. doi: 10.1021/ja9082842.

6.

From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine.

Zhu J, Wan Q, Lee D, Yang G, Spassova MK, Ouerfelli O, Ragupathi G, Damani P, Livingston PO, Danishefsky SJ.

J Am Chem Soc. 2009 Jul 8;131(26):9298-303. doi: 10.1021/ja901415s.

7.

Synthesis of sialyl Lewis(a) (sLe (a), CA19-9) and construction of an immunogenic sLe(a) vaccine.

Ragupathi G, Damani P, Srivastava G, Srivastava O, Sucheck SJ, Ichikawa Y, Livingston PO.

Cancer Immunol Immunother. 2009 Sep;58(9):1397-405. doi: 10.1007/s00262-008-0654-7. Epub 2009 Feb 4.

8.

Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine.

Deng K, Adams MM, Damani P, Livingston PO, Ragupathi G, Gin DY.

Angew Chem Int Ed Engl. 2008;47(34):6395-8. doi: 10.1002/anie.200801885. No abstract available.

Supplemental Content

Loading ...
Support Center